Vienna Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-526
Closed -$402K 59
2025
Q3
$402K Buy
+526
New +$391K 0.24% 42
2025
Q1
Sell
-1,624
Closed -$1.25M 48
2024
Q4
$1.25M Buy
+1,624
New +$1.34M 0.85% 29
2024
Q3
Sell
-238
Closed -$215K 53
2024
Q2
$215K Buy
+238
New +$190K 0.18% 47
2024
Q1
Sell
-2,409
Closed -$1.43M 51
2023
Q4
$1.43M Buy
+2,409
New +$1.41M 1.3% 20

Other funds holding LLY

Vienna Asset Management's LLY Position: Q4 2025 in Review

Vienna Asset Management sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 526 shares — an estimated $402K sold.

Vienna Asset Management first reported a position in LLY in Q4 2023 and held it in 4 quarters. The position peaked at $1.43M in Q4 2023. 4,429 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Vienna Asset Management reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • Vienna Asset Management sold 526 Eli Lilly shares in Q4 2025, an estimated $402K.
  • Vienna Asset Management first reported a position in Eli Lilly in Q4 2023 and held it in 4 quarters.
  • Vienna Asset Management's Eli Lilly position peaked at $1.43M in Q4 2023.
  • 4,429 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Vienna Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.